(Q33396613)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829041%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829041%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829041%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Sang Joon Shin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829041%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Joong Bae Ahn

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829041%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Hyun Cheol Chung

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829041%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Se-Hoon Lee

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829041%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Sun Young Rha

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829041%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

10

Yung-Jue Bang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829041%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1

Hyo Song Kim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829041%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

3

Kiyeol Kim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829041%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

6

Hei Chul Jeung

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829041%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Youngil Koh

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829041%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

5 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829041%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829041%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829041%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

5-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829041%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

395-405

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829041%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

Global cancer statistics, 2002

21 January 2018

1 reference

Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease

21 January 2018

1 reference

Sorafenib in advanced clear-cell renal-cell carcinoma

21 January 2018

1 reference

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

21 January 2018

1 reference

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

21 January 2018

1 reference

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

Sunitinib in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial

21 January 2018

1 reference

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma

21 January 2018

1 reference

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study

21 January 2018

1 reference

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

21 January 2018

1 reference

Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer

21 January 2018

1 reference

Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylate

21 January 2018

1 reference

Population pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors

21 January 2018

1 reference

Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese

21 January 2018

1 reference

30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study

21 January 2018

1 reference

Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP.

21 January 2018

1 reference

Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients

21 January 2018

1 reference

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

21 January 2018

1 reference

A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma

21 January 2018

1 reference

Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

Therapeutic drug monitoring in CML patients on imatinib

21 January 2018

1 reference